USFDA concludes inspection at Caplin Point Laboratories’ Sterile Injectable Site

07 Sep 2018 Evaluate

United States Food and Drug Administration (USFDA) has conducted an inspection at Caplin Point Laboratories’ Sterile Injectable Site (CP - IV) located at Gummudipoondi in the state of Tamil Nadu, from August 30, 2018 to September 06, 2018. This was a scheduled inspection and at the end of the inspection, there were ZERO 483s.

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.

Caplin Point Lab Share Price

1838.90 -44.00 (-2.34%)
30-Dec-2025 09:58 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1716.25
Dr. Reddys Lab 1271.35
Cipla 1488.05
Zydus Lifesciences 899.90
Lupin 2082.90
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×